Britannia Life Sciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020
Period Ending	Jan '26 Jan 20, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2020
Market Capitalization	13	12	11	15	31	-	Upgrade
Market Cap Growth	-11.11%	7.14%	-26.32%	-49.89%	-	-	Upgrade
Enterprise Value	15	23	21	25	38	-	Upgrade
Last Close Price	0.08	0.07	0.07	0.10	0.19	-	Upgrade
PE Ratio	1.58	1.65	-	3.03	-	-	Upgrade
PS Ratio	49.81	32.95	21.98	2.41	4.21	-	Upgrade
PB Ratio	2.57	1.93	1.70	1.39	5.61	-	Upgrade
P/TBV Ratio	2.57	1.93	-	-	-	-	Upgrade
P/FCF Ratio	-	-	5.43	7.89	11.34	-	Upgrade
P/OCF Ratio	-	-	5.43	7.68	10.99	-	Upgrade
EV/Sales Ratio	55.88	62.12	40.45	3.90	5.26	-	Upgrade
EV/EBITDA Ratio	-	-	-	22.64	21.88	-	Upgrade
EV/EBIT Ratio	-	-	-	25.15	23.75	-	Upgrade
EV/FCF Ratio	-	-	9.99	12.80	14.15	-	Upgrade
Debt / Equity Ratio	0.48	0.30	1.09	0.76	0.95	3.96	Upgrade
Debt / EBITDA Ratio	-	-	-	7.31	2.88	32.63	Upgrade
Debt / FCF Ratio	-	-	3.48	4.31	1.92	-	Upgrade
Asset Turnover	0.02	0.02	0.02	0.29	0.34	0.13	Upgrade
Quick Ratio	0.38	2.21	0.24	0.91	0.41	0.25	Upgrade
Current Ratio	1.00	2.72	0.26	0.92	0.42	0.25	Upgrade
Return on Equity (ROE)	-58.92%	-70.32%	-68.98%	70.57%	-343.40%	10.72%	Upgrade
Return on Assets (ROA)	-10.34%	-8.18%	-4.23%	2.78%	4.75%	1.67%	Upgrade
Return on Invested Capital (ROIC)	-16.18%	-12.52%	-5.79%	4.12%	8.46%	2.73%	Upgrade
Return on Capital Employed (ROCE)	-37.50%	-27.80%	-13.20%	5.20%	12.70%	2.60%	Upgrade
Earnings Yield	63.35%	60.75%	-41.98%	32.98%	-50.26%	-	Upgrade
FCF Yield	-	-21.53%	18.42%	12.67%	8.82%	-	Upgrade
Buyback Yield / Dilution	0.03%	-	-0.07%	-48.07%	-41.06%	-1138.06%	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.